WAYNE, Pa.--(BUSINESS WIRE)--Aug. 8, 2006--2006 Second Quarter Business and Other Financial Highlights -- Covalent Group, Inc. (Nasdaq:CVGR - News; “Covalent”), a leader in the design and management of complex clinical trials and patient disease registries for the pharmaceutical, biotechnology and medical device industries, today announced its financial results for the second quarter ended June 30, 2006 (see attached tables).
